1st Quarter - Report
DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Income
$45,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Defense DEF
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Medical/Disease Research/Clinical Labs MED
Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.